Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance
Saeedeh Keyvani‐Ghamsari, Khatereh Khorsandi, Azhar Rasul, et al.
Clinical Epigenetics (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence
Beatrice Aramini, Valentina Masciale, Giulia Grisendi, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 976-976
Open Access | Times Cited: 85
A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer
Hitesh Kumar, Neha Gupta, Rupshee Jain, et al.
Journal of Advanced Research (2023) Vol. 54, pp. 271-292
Open Access | Times Cited: 52
Hallmarks of cancer resistance
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109979-109979
Open Access | Times Cited: 14
The paradigm of drug resistance in cancer: an epigenetic perspective
Swagata Adhikari, Apoorva Bhattacharya, Santanu Adhikary, et al.
Bioscience Reports (2022) Vol. 42, Iss. 4
Open Access | Times Cited: 43
Cancer Stem Cells and Their Possible Implications in Cervical Cancer: A Short Review
Riccardo Di Fiore, Sherif Suleiman, Rosa Drago‐Ferrante, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 5167-5167
Open Access | Times Cited: 40
ncRNA-mediated ceRNA regulatory network: Transcriptomic insights into breast cancer progression and treatment strategies
Shu Yang, Xiaomin Wang, Xintong Zhou, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114698-114698
Open Access | Times Cited: 35
tRNA-derived fragments: Key determinants of cancer metastasis with emerging therapeutic and diagnostic potentials
Mohammad Salehi, Mohammad Javad Kamali, Aliakbar Rajabzadeh, et al.
Archives of Biochemistry and Biophysics (2024) Vol. 753, pp. 109930-109930
Closed Access | Times Cited: 10
Advanced drug delivery platforms target cancer stem cells
MirAhmad Mazloomi, Abolfazl Doustmihan, Sajjad Alimohammadvand, et al.
Asian Journal of Pharmaceutical Sciences (2025), pp. 101036-101036
Open Access
HDAC Inhibitors: Dissecting Mechanisms of Action to Counter Tumor Heterogeneity
Dimitris Karagiannis, Θεόδωρος Ράμπιας
Cancers (2021) Vol. 13, Iss. 14, pp. 3575-3575
Open Access | Times Cited: 51
Cancer stem cells and tumor heterogeneity: Deciphering the role in tumor progression and metastasis
Upasana Kapoor-Narula, Nibedita Lenka
Cytokine (2022) Vol. 157, pp. 155968-155968
Closed Access | Times Cited: 28
Novel epigenetic therapeutic strategies and targets in cancer
Quratulain Babar, Ayesha Saeed, Tanveer A. Tabish, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2022) Vol. 1868, Iss. 12, pp. 166552-166552
Open Access | Times Cited: 27
Bromodomain-Containing Protein 9 Regulates Signaling Pathways and Reprograms the Epigenome in Immortalized Human Uterine Fibroid Cells
Qiwei Yang, Somayeh Vafaei, Ali Falahati, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 905-905
Open Access | Times Cited: 6
The Role of TAMs in the Regulation of Tumor Cell Resistance to Chemotherapy
Ryan McWhorter, Benjamin Bonavida
Critical Reviews™ in Oncogenesis (2024) Vol. 29, Iss. 4, pp. 97-125
Closed Access | Times Cited: 5
New insights into Notch signaling as a crucial pathway of pancreatic cancer stem cell behavior by chrysin-polylactic acid-based nanocomposite
Eman M. Ragab, Doaa M. El Gamal, Fares F. Elnajjar, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
The molecular impact of miR-326 in acute lymphoblastic leukemia and its cross talk with P53
Saba Shafieizadegan, Narges Aberuyi, Soheila Rahgozar
Annals of Hematology (2025)
Open Access
Integrating alternative therapies in overcoming chemotherapy resistance in tumors
Sana S. Alqarni, Najeeb Ullah Khan
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
TFF3 facilitates dormancy of anti-estrogen treated ER+ mammary carcinoma
Shu Chen, Xi Zhang, Basappa Basappa, et al.
Communications Medicine (2025) Vol. 5, Iss. 1
Open Access
Epigenetic regulation of reprogramming and pluripotency: insights from histone modifications and their implications for cancer stem cell therapies
Wooli Bae, Eun A., Myon‐Hee Lee
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Signaling pathways governing glioma cancer stem cells behavior
Ava Nasrolahi, Shirin Azizidoost, Klaudia Radoszkiewicz, et al.
Cellular Signalling (2022) Vol. 101, pp. 110493-110493
Closed Access | Times Cited: 26
Epi‐immunotherapy for cancers: rationales of epi‐drugs in combination with immunotherapy and advances in clinical trials
Yang Xu, Ping Li, Yang Liu, et al.
Cancer Communications (2022) Vol. 42, Iss. 6, pp. 493-516
Open Access | Times Cited: 22
Drug-resistant profiles of extracellular vesicles predict therapeutic response in TNBC patients receiving neoadjuvant chemotherapy
Min Woo Kim, Hyojung Lee, Suji Lee, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Keep your eyes peeled for long noncoding RNAs: Explaining their boundless role in cancer metastasis, drug resistance, and clinical application
Ganesh Kumar Barik, Osheen Sahay, Abhayananda Behera, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 2, pp. 188612-188612
Closed Access | Times Cited: 28
A Gold Nanoparticle Bioconjugate Delivery System for Active Targeted Photodynamic Therapy of Cancer and Cancer Stem Cells
Onyisi Christiana Didamson, Rahul Chandran, Heidi Abrahamse
Cancers (2022) Vol. 14, Iss. 19, pp. 4558-4558
Open Access | Times Cited: 20
A perspective on emerging therapies in metastatic colorectal cancer: Focusing on molecular medicine and drug resistance
Anggraeni Endah Kusumaningrum, Sarce Makaba, Eyhab Ali, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 1
Closed Access | Times Cited: 3
BMP2 as a promising anticancer approach: functions and molecular mechanisms
Tongtong Li, Yong-wei Lai, Xu Han, et al.
Investigational New Drugs (2022) Vol. 40, Iss. 6, pp. 1322-1332
Closed Access | Times Cited: 16
Page 1 - Next Page

Scroll to top